The medication further slows gastric emptying, which could exacerbate pre-existing motility issues
Combined protocols (BPC-157 + TB-500) have accumulated substantial researcher attention for their complementary mechanisms
Of greater concern are potential risks from combination use: Hypoglycaemia risk: Retatrutide enhances insulin secretion in a glucose-dependent manner, which carries a low intrinsic hypoglycaemia risk when used alone
Managing expectations is important with any peptide protocol
Its going to fix all your tendon problems, your muscle injuries, youre going to be stronger, youre going to be faster, Spittler said
Less common: Nausea, dizziness, or headache